Predilife (XPAR:ALPRE) Price-to-Tangible-Book : (As of May. 27, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Predilife Price-to-Tangible-Book?

As of today (2024-05-27), Predilife's share price is €7.00. Predilife's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was €-0.27. Hence, Predilife's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Predilife's Price-to-Tangible-Book or its related term are showing as below:

During the past 7 years, Predilife's highest Price to Tangible Book Ratio was 2166.67. The lowest was 34.04. And the median was 1100.36.

XPAR:ALPRE's Price-to-Tangible-Book is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.475
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Predilife's share price is €7.00. Predilife's Book Value per Sharefor the quarter that ended in Jun. 2023 was €-0.27. Hence, Predilife's P/B Ratio of today is .

Predilife Price-to-Tangible-Book Historical Data

The historical data trend for Predilife's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predilife Price-to-Tangible-Book Chart

Predilife Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

Get a 7-Day Free Trial

34.04

Predilife Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Predilife's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Predilife's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Predilife's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Predilife's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Predilife's Price-to-Tangible-Book falls into.

Predilife Price-to-Tangible-Book Calculation

Predilife's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	7.00	/	-0.272
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Predilife Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Predilife's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Predilife (XPAR:ALPRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Predilife SA (XPAR:ALPRE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

114 rue Edouard Vaillant Espace Maurice Tubiana, Villejuif, Paris, FRA, 94800

Website

https://www.predilife.com

Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.

Predilife (XPAR:ALPRE) Headlines

No Headlines